title: [Gamma globulin in secondary antibody deficiency syndrome].
abstract: 12 patients with secondary antibody deficiency syndrome received a new gammaglobulin compound intravenously (lyoph. SRK Sandoz). The drug was given in a 3% NaCl-solution once to four times. At the end of the infusion of 6 g gammaglobulin and after one week, serum levels were significantly higher. Gammaglobulin intravenously was well tolerated in all cases. Severe infections during the period of treatment were not observed.
mesh_terms: D000918:Antibody Specificity; D004341:Drug Evaluation; D006801:Humans; D007141:Immunoglobulin Fc Fragments; D007074:Immunoglobulin G; D007153:Immunologic Deficiency Syndromes / Q000209:etiology / Q000628:therapy*; D007938:Leukemia / Q000150:complications; D008223:Lymphoma / Q000150:complications; D010954:Plasmacytoma / Q000150:complications; D005719:gamma-Globulins / Q000627:therapeutic use*
chemical_list: D007141:Immunoglobulin Fc Fragments; D007074:Immunoglobulin G; D005719:gamma-Globulins
vernacular_title: Gammaglobulin bei sekundärem Antikörper-Mangelsyndrom.